Laurus Labs Limited
NSE:LAURUSLABS.NS
Overview | Financials
Company Name | Laurus Labs Limited |
Symbol | LAURUSLABS.NS |
Currency | INR |
Price | 499.35 |
Market Cap | 269,229,046,650 |
Dividend Yield | 0.27% |
52-week-range | 360.85 - 518 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Satyanarayana Chava M.Sc., Ph.D. |
Website | https://www.lauruslabs.com |
An error occurred while fetching data.
About Laurus Labs Limited
Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C therapeutic
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD